Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of SPLUNC1's ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airways.
Hobbs CA, Blanchard MG, Kellenberger S, Bencharit S, Cao R, Kesimer M, Walton WG, Redinbo MR, Stutts MJ, Tarran R. Hobbs CA, et al. Among authors: tarran r. FASEB J. 2012 Oct;26(10):4348-59. doi: 10.1096/fj.12-207431. Epub 2012 Jul 13. FASEB J. 2012. Retraction in: FASEB J. 2013 May;27(5):2081. doi: 10.1096/fj.12-207431RET PMID: 22798424 Free PMC article. Retracted.
Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways.
Garland AL, Walton WG, Coakley RD, Tan CD, Gilmore RC, Hobbs CA, Tripathy A, Clunes LA, Bencharit S, Stutts MJ, Betts L, Redinbo MR, Tarran R. Garland AL, et al. Among authors: tarran r. Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):15973-8. doi: 10.1073/pnas.1311999110. Epub 2013 Sep 16. Proc Natl Acad Sci U S A. 2013. PMID: 24043776 Free PMC article.
Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures.
Hobbs CA, Blanchard MG, Alijevic O, Tan CD, Kellenberger S, Bencharit S, Cao R, Kesimer M, Walton WG, Henderson AG, Redinbo MR, Stutts MJ, Tarran R. Hobbs CA, et al. Among authors: tarran r. Am J Physiol Lung Cell Mol Physiol. 2013 Dec;305(12):L990-L1001. doi: 10.1152/ajplung.00103.2013. Epub 2013 Oct 11. Am J Physiol Lung Cell Mol Physiol. 2013. PMID: 24124190 Free PMC article.
Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease.
Terryah ST, Fellner RC, Ahmad S, Moore PJ, Reidel B, Sesma JI, Kim CS, Garland AL, Scott DW, Sabater JR, Carpenter J, Randell SH, Kesimer M, Abraham WM, Arendshorst WJ, Tarran R. Terryah ST, et al. Among authors: tarran r. Am J Physiol Lung Cell Mol Physiol. 2018 Jan 1;314(1):L192-L205. doi: 10.1152/ajplung.00546.2016. Epub 2017 Oct 5. Am J Physiol Lung Cell Mol Physiol. 2018. PMID: 28982737 Free PMC article.
SPLUNC1: a novel marker of cystic fibrosis exacerbations.
Khanal S, Webster M, Niu N, Zielonka J, Nunez M, Chupp G, Slade MD, Cohn L, Sauler M, Gomez JL, Tarran R, Sharma L, Dela Cruz CS, Egan M, Laguna T, Britto CJ. Khanal S, et al. Among authors: tarran r. Eur Respir J. 2021 Nov 11;58(5):2000507. doi: 10.1183/13993003.00507-2020. Print 2021 Nov. Eur Respir J. 2021. PMID: 33958427 Free PMC article.
141 results